The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utilization of the sexual health service from the prostate cancer supportive care program: A chart review.
 
Jennifer Bossio
No Relationships to Disclose
 
Christine Zarowski
No Relationships to Disclose
 
Stacy Elliott
No Relationships to Disclose
 
Lindsay Hedden
No Relationships to Disclose
 
Phil Pollock
No Relationships to Disclose
 
Maria Spillane
No Relationships to Disclose
 
Eugenia Wu
No Relationships to Disclose
 
Natalie Nunez
No Relationships to Disclose
 
Anna Branch
No Relationships to Disclose
 
Larry Goldenberg
Leadership - Genyous
 
Celestia S. Higano
Employment - CTI (I)
Leadership - CTI (I)
Stock and Other Ownership Interests - CTI (I)
Consulting or Advisory Role - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Endocyte; Ferring; Medivation; MorphoSys; Myriad Genetics; Orion; Parexel
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Genentech (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Asana Biosciences; Astellas Pharma; Bayer; Blue Earth Diagnostics; Churchill Pharmaceuticals; Clovis Oncology; Dendreon; Emergent BioSolutions; Emergent BioSolutions; Endocyte; Ferring; Genentech; Menarini; Myriad Genetics; Orion